ConductScience.org, home

Paper8306418

Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography.

van Tellingen O and 6 others. Cancer Chemother Pharmacol, 1994. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography. Papers, record 8306418. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8306418

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1994
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.13
iCite
Revised in PubMed
2019-08-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Tellingen OO
2Sonneveldt ALA L
3Beijnen JHJ H
4Nooijen WJW J
5Kettenes-van den Bosch JJJ J
6Versluis CC
7Bult AA

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
VinblastineMajor topic
Animals
Chromatography, High Pressure Liquid
Male
Mice
Mice, Inbred Strains
Tissue Distribution

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1329987Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).Cancer Treat Rev1977https://conductscience.org/library/papers/329987PubMed
21524896Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts.Eur J Cancer1992https://conductscience.org/library/papers/1524896PubMed
31822176Analytical methods for the determination of vinca alkaloids in biological specimens: a survey of the literature.J Pharm Biomed Anal1991https://conductscience.org/library/papers/1822176PubMed
45743691Historical background of Vinca alkaloid research and areas of future interest.Cancer Chemother Rep1968https://conductscience.org/library/papers/5743691PubMed
51618962Biodetermination of N-(deacetyl-O-4-vinblastoyl-23)-L-tryptophan, a metabolite of vintriptol, by high-performance liquid chromatography with fluorescence detection.J Chromatogr1992https://conductscience.org/library/papers/1618962PubMed
63898995Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).Anticancer Res1985https://conductscience.org/library/papers/3898995PubMed
72015595Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363.Cancer Res1991https://conductscience.org/library/papers/2015595PubMed
813719013Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action.Cancer Res1960https://conductscience.org/library/papers/13719013PubMed
96359081Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid.Pharmacotherapy1983https://conductscience.org/library/papers/6359081PubMed
108324870Tissue disposition, excretion and metabolism of vinblastine in mice as determined by high-performance liquid chromatography.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8324870PubMed
112225313Clinical pharmacokinetics of intravenously injected tritiated vinzolidine.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2225313PubMed
121206487Alkaloids of Vinca rosea L. (Catharanthus roseus G. Don) XXXVI: Isolation and characterization of new dimeric alkaloids.J Pharm Sci1975https://conductscience.org/library/papers/1206487PubMed
131851385A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer.Am J Clin Oncol1991https://conductscience.org/library/papers/1851385PubMed
141444238Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives (review).Anticancer Res1992https://conductscience.org/library/papers/1444238PubMed
154761279Vinca alkaloids. XXXII. Microbiological conversions of vindoline, a major alkaloid from Vinca rosea L.Helv Chim Acta1973https://conductscience.org/library/papers/4761279PubMed
1614070392THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.Cancer Res1963https://conductscience.org/library/papers/14070392PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
7920369Bioanalysis and pharmacokinetics of (investigational) vinca alkaloids.Pharm World Sci1994https://conductscience.org/library/papers/7920369

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8306418

GET https://conductscience.org/api/papers/v1/8306418/authors